Lisdexamfetamine for ADHD and Autism

"Affirmative. According to data hosted on clinicaltrials.gov, this medical research is presently seeking volunteers and was initially posted in September of 2018. The most recent update occurred at the end of March 2021 with 40 patients needed from 1 site."

"Affirmative. Data from clinicaltrials.gov indicates that this study, which was initially made available on September 26th 2018, is actively recruiting volunteers. Approximately 40 people are needed to be sourced at a single medical site."

"Research into this therapeutic option has been ongoing since 2018, beginning with an initial trial sponsored by Shire. This clinical study was successful enough to warrant Phase 4 drug approval and today there are 6 active trials occurring across 3 cities in 3 different countries."

"Presently, 6 different medical trials are underway studying this intervention with 3 of them in their final stage. In addition to Iowa City, Iowa there are 5 other locations conducting clinical studies for the treatment."

"To be included in this trial, participants must have an age between 6 to 12. According to the data, there are 519 trials conducted for patients below 18 years old and another 681 clinical studies designed for elderly people above 65."

"By virtue of being a Phase 4 trial, the safety of this medical intervention is estimated to be 3 on our 1-3 scale. This indicates that there is ample evidence to support its approval for use."

"To be eligible for this research, those with autism spectrum disorder must fall between the ages of 6 to 12. The team are expecting 40 people to join their investigation."